Author/Authors :
Azarmina, Mohsen Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Soheilian, Masoud Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Ahmadieh, Hamid Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Azarmina, Hossein Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Purpose: To evaluate electroretinogram (ERG) changes in the contralateral normal
appearing eye of patients with unilateral acute necrotizing herpetic retinitis (NHR).
Methods: This interventional case series includes subjects with acute unilateral NHR. All
patients were treated with intravenous followed by oral acyclovir and systemic steroids.
Main outcome measures were changes in a- and b-wave amplitudes of scotopic and
photopic full-field ERG in the sound eye, 1 and 3 months after therapy as compared
to baseline. Twenty normal subjects served as controls.
Results: Forty eyes of 20 patients including 12 male and 8 female subjects with mean
age of 44.1±11.5 (range 22 to 66) years were studied. Twenty unaffected eyes were
the subject of the current study. The retina in all of these eyes remained intact during
the course of the study. In the sound eyes, mean b-wave amplitude of the maximal
combined response ERG before initiation of treatment was 229.5±38.8 microvolts which
increased to 356.1±34.0 (P<0.001) and 365.8±32.7 (P<0.001) microvolts 1 and 3 months
after treatment, respectively. Corresponding figures for b-wave amplitudes of the cone
response ERG were 24.9±6.0, 47.0±12.9 (P<0.001) and 52.8±12.7 (P<0.001) microvolts,
respectively. Visual acuity of all sound eyes remained unchanged throughout the study.
Conclusion: Despite normal retinal appearance and intact visual acuity in the sound eyes
of patients with NHR, electrophysiological changes were observed. Prompt diagnosis
and management of NHR and continuation of medication for 3 months may reverse
subclinical ERG changes and reduce the risk of progression to overt clinical disease.